The development of in vivo measures to assess the impact of sex-drive reducing medications in an offender with an intellectual disability

dc.contributor.authorRea, Jerry A.
dc.contributor.authorDixon, Michael R.
dc.contributor.authorZettle, Robert D.
dc.contributor.authorWright, Kasey L.
dc.date.accessioned2017-05-01T01:46:36Z
dc.date.available2017-05-01T01:46:36Z
dc.date.issued2017-04
dc.descriptionClick on the DOI link to access the article (may not be free).en_US
dc.description.abstractThe ability to adequately evaluate medications in the treatment of paraphilias has been limited by reliance upon self-report as a measure of effectiveness over periods of time that may be too short to detect reoffending. One solution to this shortcoming is the development of valid, long-term, stable assessment measures. The purpose of this case study was to analyze the effects of Prozac and Provera on an array of behaviors germane to the successful treatment of paraphilias, including: (a) sexualarousalinthe laboratory and natural environment, (b) sexual thoughts (deviant and nondeviant) accompanied by arousal in the natural environment, and (c) overt actions in the community associated with increased risk of reoffending over a 31-month period for an exhibitionist with an intellectual disability. Despite the ineffectiveness of the medications, themeasures demonstrated long-term, differentiated significant clinical responding; further underscored the importance of assessing deviant sexual arousal and adherence to relapse-prevention procedures in the natural environment; and provided a new methodology to assess sexual preoccupations and sexual arousal. Use of these in vivo measures raises questions regarding their potential to improve the predictability of risk assessments, and serve as an aide in the analysis of whether a treatment procedure is effective for an individual.en_US
dc.identifier.citationRea, J.A., Dixon, M.R., Zettle, R.D. et al. Arch Sex Behav (2017) 46: 843en_US
dc.identifier.issn0004-0002
dc.identifier.otherWOS:000398045200025
dc.identifier.urihttp://dx.doi.org/10.1007/s10508-016-0832-1
dc.identifier.urihttp://hdl.handle.net/10057/13056
dc.language.isoen_USen_US
dc.publisherSpringer International Publishingen_US
dc.relation.ispartofseriesArchives of Sexual Behavior;v.46:no.3
dc.rights.holderCopyright 2017 Springer International Publishing AG.en_US
dc.subjectSexual preoccupationen_US
dc.subjectDeviant sexual arousalen_US
dc.subjectParaphiliasen_US
dc.subjectIntellectual disabilityen_US
dc.titleThe development of in vivo measures to assess the impact of sex-drive reducing medications in an offender with an intellectual disabilityen_US
dc.typeArticleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.59 KB
Format:
Item-specific license agreed upon to submission
Description: